These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38976344)

  • 1. Post-Coronavirus Disease-2019 Rhino-orbital Mucormycosis: A Case Report.
    Shrestha T; Parajuli S; Keshari R; Kharbuja P; Sharma S; Shrestha JK
    Nepal J Ophthalmol; 2023 Jul; 15(30):108-115. PubMed ID: 38976344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient.
    Fairley C; Sullivan TJ; Bartley P; Allworth T; Lewandowski R
    Ophthalmology; 2000 Mar; 107(3):555-8. PubMed ID: 10711895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
    Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of bilateral rhino-orbital cerebral mucormycosis.
    Lam SC; Yuen HKL
    Hong Kong Med J; 2019 Oct; 25(5):408-409. PubMed ID: 31761754
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
    Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y;
    Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhinocerebral mucormycosis with orbital and intracranial extension: a case report and review of optimum management.
    Munir N; Jones NS
    J Laryngol Otol; 2007 Feb; 121(2):192-5. PubMed ID: 17134533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.
    Liang KP; Tleyjeh IM; Wilson WR; Roberts GD; Temesgen Z
    J Clin Microbiol; 2006 Mar; 44(3):892-8. PubMed ID: 16517873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
    Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
    Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience.
    Ramamurthy LB; Bhandari R; Kanakpur S; Thejaswini P
    Indian J Ophthalmol; 2022 Mar; 70(3):1019-1024. PubMed ID: 35225564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially.
    Jiang N; Zhao G; Yang S; Lin J; Hu L; Che C; Wang Q; Xu Q
    BMC Ophthalmol; 2016 Jan; 16():10. PubMed ID: 26758904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis.
    Murthy R; Bagchi A; Gote Y; Desai S
    Indian J Ophthalmol; 2022 Jan; 70(1):302-305. PubMed ID: 34937263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of rhino-orbital mucormycosis without exenteration: the use of multiple treatment modalities.
    Pelton RW; Peterson EA; Patel BC; Davis K
    Ophthalmic Plast Reconstr Surg; 2001 Jan; 17(1):62-6. PubMed ID: 11206749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive use of saturated solution of potassium iodide (SSKI) with liposomal amphotericin B (L-AMB) in mucormycosis achieves favorable response, shortened dose and duration of amphotericin: A retrospective study from a COVID-19 tertiary care center.
    Mrig S; Sardana K; Arora P; Narula V; Arora S; Kapoor A; Baruah RR; Sen P; Agarwal S; Sachdeva S; Dewan A; Panesar S
    Am J Otolaryngol; 2022; 43(3):103465. PubMed ID: 35429848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome.
    Songu M; Unlu HH; Gunhan K; Ilker SS; Nese N
    Am J Rhinol; 2008; 22(1):98-103. PubMed ID: 18284868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhino-orbito-cerebral mucormycosis: a treatment dilemma.
    Jeevanan J; Gendeh BS; Faridah HA; Vikneswaran T
    Med J Malaysia; 2006 Mar; 61(1):106-8. PubMed ID: 16708746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal Artery Calciphylaxis Presenting as Temporal Arteritis in a Case of Rhinoorbitocerebral Mucormycosis.
    Chi M; Kim HJ; Basham R; Yoon MK; Vagefi R; Kersten RC
    Ophthalmic Plast Reconstr Surg; 2015; 31(5):e132-5. PubMed ID: 24853118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study.
    Dave TV; Gopinathan Nair A; Hegde R; Vithalani N; Desai S; Adulkar N; Kamal S; Mittal R; Bradoo RA
    Ophthalmic Plast Reconstr Surg; 2021 Sep-Oct 01; 37(5):488-495. PubMed ID: 34314399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control.
    Mitra S; Janweja M; Sengupta A
    Eur Arch Otorhinolaryngol; 2022 May; 279(5):2417-2422. PubMed ID: 34309754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19.
    Shakrawal J; Sharma V; Goyal A; Kumar D; Meena S; Tiwari S; Jain V; Elhence P; Soni K; Choudhury B; Bhatnagar K; Garg MK; Misra S
    Int Ophthalmol; 2023 Jun; 43(6):1919-1926. PubMed ID: 36427099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
    Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
    Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.